67 episodes

A weekly podcast for pharmacists, physicians, physician assistants, and nurse practitioners who are interested in learning more about clinical pharmacology topics. To claim pharmacology CE credit or to get a copy of presentation slides, visit https://ce.mayo.edu/pharmacypodcast. Produced by @MayoMedEd. Hosted by @garrett_schramm

Mayo Clinic Pharmacy Grand Rounds Mayo Clinic

    • Education
    • 4.7 • 29 Ratings

A weekly podcast for pharmacists, physicians, physician assistants, and nurse practitioners who are interested in learning more about clinical pharmacology topics. To claim pharmacology CE credit or to get a copy of presentation slides, visit https://ce.mayo.edu/pharmacypodcast. Produced by @MayoMedEd. Hosted by @garrett_schramm

    CoN(S)taminant or Pathogen? Assessment and Analysis of Coagulase-Negative Staphylococcus Infections

    CoN(S)taminant or Pathogen? Assessment and Analysis of Coagulase-Negative Staphylococcus Infections

    Michaela E. Wermers, Pharm.D., describes the epidemiology and pathogenicity of coagulase-negative Staphylococcus (CoNS) species, outlines an evidence-based approach to determine the clinical significance of CoNS isolates and identifies empiric and definitive treatment regimens for pathogenic CoNS. 


    For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!


    You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

    • 34 min
    Primary Treatment for Multiple Myeloma: Three’s Company, is Four a Crowd?

    Primary Treatment for Multiple Myeloma: Three’s Company, is Four a Crowd?

    Sydney E. Schultz, PharmD identifies signs, symptoms, and diagnostic criteria for multiple myeloma, reviews pharmacology of medications used as primary treatment for multiple myeloma and discusses recent literature regarding four-drug regimens. 


    For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!


    You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

    • 38 min
    (sub)Massive Controversy: Thrombolytics for Pulmonary Embolism

    (sub)Massive Controversy: Thrombolytics for Pulmonary Embolism

    Cassandra J. Schmitt, PharmD (@cjschmitt2) Identifies the risk stratifications for submassive pulmonary embolism, discusses efficacy and safety outcomes for thrombolytics in submassive pulmonary embolism and selects the ideal candidate to receive thrombolysis for a submassive pulmonary embolism. 


    For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!


    You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

    • 46 min
    The Clot Thickens: Anticoagulation in ECMO

    The Clot Thickens: Anticoagulation in ECMO

    Hannah M. Brokmeier, PharmD (@hannahbrokmeier) compares and contrasts the pharmacokinetic and pharmacodynamic properties of heparin and bivalirudin in extracorporeal support, identifies clinical scenarios that favor either heparin or bivalirudin for anticoagulation in ECMO and selects a preferred agent for ECMO when either heparin or bivalirudin are acceptable.


    For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!


    You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

    • 36 min
    Mu and Improved: Flushing Opioid-Induced Constipation Down the Drain

    Mu and Improved: Flushing Opioid-Induced Constipation Down the Drain

    Danielle M. Hess, PharmD (@dhess_09) describes the pathophysiology of opioid-induced constipation (OIC), evaluates literature depicting the safety and efficacy of peripherally-acting mu-opioid receptor antagonists (PAMORAs) for the treatment of OIC and applies the clinical pearls of PAMORAs to patient care.


    For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!


    You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

    • 40 min
    Medications for Alcohol Use Disorder

    Medications for Alcohol Use Disorder

    Audrey J. Umbreit, PharmD, BCACP describes alcohol use disorder (AUD) as a chronic disease, identifies evidence-based medications for treatment of AUD and selects a medication based on individual patient factors to treat AUD.


    For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!


    You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

    • 43 min

Customer Reviews

4.7 out of 5
29 Ratings

29 Ratings

Top Podcasts In Education

You Might Also Like

More by Mayo Clinic